Abstract
Background and aim To examine the association between baseline level and change of autonomic nervous function with subsequent development of arterial stiffness.
Methods Autonomic nervous function was assessed of 4,901 participants of the Whitehall II occupational cohort by heart rate variability (HRV) indices and resting heart rate (rHR) three times between 1997-2009, while arterial stiffness was assessed by carotid-femoral pulse wave velocity (PWV) measured twice between 2007-2013. First, individual HRV/rHR levels and annual changes were estimated. Then, we modelled the development of PWV by HRV/rHR using linear mixed effect models. First, we adjusted for sex and ethnicity (model 1), and then for socioeconomic and lifestyle factors, various clinical measurements, and medications (model 2).
Results A decrease in HRV and unchanged rHR was associated with subsequent higher levels of PWV, but the effect of a change in HRV was less pronounced at higher ages. A typical individual aged 65 years with a SDNN level of 30 ms and a 2% annual decrease in SDNN had 1.32 (0.95; 1.69) higher PWV compared to one with the same age and SDNN level but with a 1% annual decrease in SDNN. Further adjustment had no major effect on the results.
Conclusion People who experience a steeper decline of autonomic nervous function have higher levels of arterial stiffness. However, the association was weaker at higher ages.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by Steno Diabetes Center Aarhus, which is partially funded by an unrestricted donation from the Novo Nordisk Foundation
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Whitehall II study was reviewed and approved by the UK NHS Health Research Authority London-Harrow Ethics Committee and written informed consent was obtained from each participant at each examination phase. The study was conducted according to the principles of the Helsinki Declaration.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Abbreviations
- ECG
- Electrocardiogram
- CAN
- Cardiovascular autonomic neuropathy
- CVD
- Cardiovascular disease
- HF power
- High-frequency power
- HRV
- Heart rate variability
- LF power
- Low-frequency power
- PWV
- pulse wave velocity
- SDNN
- The standard deviation of normal-to-normal R-R intervals
- rHR
- Resting heart rate
- RMSSD
- The root mean square of the sum of the squares of differences between consecutive normal-to-normal R-R intervals
